Cargando…

Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is a common cancer in the world, and its incidence is increasing yearly. Hepatitis B virus (HBV) infection and hepatitis C virus (HCV) infection are important causes of HCC. Liver cirrhosis, age, sex, smoking and drinking, and metabolic risk factors will increase the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xinhe, Guan, Lin, Tian, Haoyu, Zeng, Zilu, Chen, Jiayu, Huang, Die, Sun, Ji, Guo, Jiaqi, Cui, Huipeng, Li, Yiling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458967/
https://www.ncbi.nlm.nih.gov/pubmed/34568017
http://dx.doi.org/10.3389/fonc.2021.686962
_version_ 1784571419115388928
author Zhang, Xinhe
Guan, Lin
Tian, Haoyu
Zeng, Zilu
Chen, Jiayu
Huang, Die
Sun, Ji
Guo, Jiaqi
Cui, Huipeng
Li, Yiling
author_facet Zhang, Xinhe
Guan, Lin
Tian, Haoyu
Zeng, Zilu
Chen, Jiayu
Huang, Die
Sun, Ji
Guo, Jiaqi
Cui, Huipeng
Li, Yiling
author_sort Zhang, Xinhe
collection PubMed
description Hepatocellular carcinoma (HCC) is a common cancer in the world, and its incidence is increasing yearly. Hepatitis B virus (HBV) infection and hepatitis C virus (HCV) infection are important causes of HCC. Liver cirrhosis, age, sex, smoking and drinking, and metabolic risk factors will increase the risk of cancer in HBV/HCV patients. And viral load, APRI, FIB-4, and liver stiffness can all predict the risk of HCC in patients with viral infection. In addition, effective prevention strategies are essential in reducing the risk of HCC. The prevention of HCC involves mainly tertiary prevention strategies, while the primary prevention is based on standardized vaccine injections to prevent the occurrence of HBV/HCV. Eliminating the route of transmission and vaccination will lead to a decrease in the incidence of HCC. Secondary prevention involves effective antiviral treatment of HBV/HCV to prevent the disease from progressing to HCC, and tertiary prevention is actively treating HCC to prevent its recurrence.
format Online
Article
Text
id pubmed-8458967
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84589672021-09-24 Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma Zhang, Xinhe Guan, Lin Tian, Haoyu Zeng, Zilu Chen, Jiayu Huang, Die Sun, Ji Guo, Jiaqi Cui, Huipeng Li, Yiling Front Oncol Oncology Hepatocellular carcinoma (HCC) is a common cancer in the world, and its incidence is increasing yearly. Hepatitis B virus (HBV) infection and hepatitis C virus (HCV) infection are important causes of HCC. Liver cirrhosis, age, sex, smoking and drinking, and metabolic risk factors will increase the risk of cancer in HBV/HCV patients. And viral load, APRI, FIB-4, and liver stiffness can all predict the risk of HCC in patients with viral infection. In addition, effective prevention strategies are essential in reducing the risk of HCC. The prevention of HCC involves mainly tertiary prevention strategies, while the primary prevention is based on standardized vaccine injections to prevent the occurrence of HBV/HCV. Eliminating the route of transmission and vaccination will lead to a decrease in the incidence of HCC. Secondary prevention involves effective antiviral treatment of HBV/HCV to prevent the disease from progressing to HCC, and tertiary prevention is actively treating HCC to prevent its recurrence. Frontiers Media S.A. 2021-09-09 /pmc/articles/PMC8458967/ /pubmed/34568017 http://dx.doi.org/10.3389/fonc.2021.686962 Text en Copyright © 2021 Zhang, Guan, Tian, Zeng, Chen, Huang, Sun, Guo, Cui and Li https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhang, Xinhe
Guan, Lin
Tian, Haoyu
Zeng, Zilu
Chen, Jiayu
Huang, Die
Sun, Ji
Guo, Jiaqi
Cui, Huipeng
Li, Yiling
Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma
title Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma
title_full Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma
title_fullStr Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma
title_full_unstemmed Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma
title_short Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma
title_sort risk factors and prevention of viral hepatitis-related hepatocellular carcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458967/
https://www.ncbi.nlm.nih.gov/pubmed/34568017
http://dx.doi.org/10.3389/fonc.2021.686962
work_keys_str_mv AT zhangxinhe riskfactorsandpreventionofviralhepatitisrelatedhepatocellularcarcinoma
AT guanlin riskfactorsandpreventionofviralhepatitisrelatedhepatocellularcarcinoma
AT tianhaoyu riskfactorsandpreventionofviralhepatitisrelatedhepatocellularcarcinoma
AT zengzilu riskfactorsandpreventionofviralhepatitisrelatedhepatocellularcarcinoma
AT chenjiayu riskfactorsandpreventionofviralhepatitisrelatedhepatocellularcarcinoma
AT huangdie riskfactorsandpreventionofviralhepatitisrelatedhepatocellularcarcinoma
AT sunji riskfactorsandpreventionofviralhepatitisrelatedhepatocellularcarcinoma
AT guojiaqi riskfactorsandpreventionofviralhepatitisrelatedhepatocellularcarcinoma
AT cuihuipeng riskfactorsandpreventionofviralhepatitisrelatedhepatocellularcarcinoma
AT liyiling riskfactorsandpreventionofviralhepatitisrelatedhepatocellularcarcinoma